Artificial intelligence (AI) models have shown great accuracy in health screening. However, for real-world implementation, high accuracy may not guarantee cost-effectiveness. Improving AI’s sensitivity finds more high-risk patients but may raise medical costs while…
Continue Reading
Parkview Health has revolutionized diabetic retinopathy testing, making it more accessible through point-of-care tools. This initiative addresses the challenges of low completion rates due to barriers like time, finances, and transportation. By strategically placing…
Continue Reading
Living with diabetes is challenging. So is treating it, with a myriad of factors determining or influencing a person’s health.THE PROBLEM
In addition, those living with diabetes must take care of themselves by performing daily,…
By Shania Kennedy
January 18, 2024 – A research team from Johns Hopkins Children’s Center has found that an autonomous artificial intelligence (AI) tool to screen youth populations for diabetic eye disease (DED) can also increase…
Continue Reading
The ADA Scientific Sessions showcased advancements in diabetes care, including an AI tool for predicting diabetic retinopathy progression and a glucose sensing and delivery device for Type 1 diabetes. The AI tool improves risk…
Continue Reading
Last year, Eyenuk CEO Kaushal Solanki told MedCity News his company is on a mission to “screen every eye in the world” by leveraging its AI-powered disease detection technologies.
Eyenuk still has a lot of…
Aegis Ventures and Northwell Holdings, the investment arm of the New York-based health system, on Tuesday launched Optain, a company that aims to use AI-backed retinal imaging to catch early signs of disease. The…
Continue Reading
What You Should Know:Today Ascertain, the partnership between Aegis Ventures and Northwell Holdings, announced a $12M seed funding round to launch its first company, Optain, an artificial intelligence (AI) company leveraging retinal imaging to…
Continue Reading
